Eye’s Clinical manifestation in Covid-19 Infection
Keywords:Clinical manifestations, COVID-19, eyes
Coronavirus Disease 2019 (COVID-19) is a new kind of disease that has never been identified before in humans. The disease is caused by the novel severe acute respiratory syndrome-coronavirus-2 (Sars-CoV-2), which will make the person who is attacked have symptoms of pneumonia. Ocular transmission in the case of COVID-19 should not be ignored. Obtained data on a study conducted in China, positive patients with COVID-19 can have ocular manifestations, such as epiphora, conjunctival congion, chemosis, and these occur in patients with more severe systemic manifestations. Other studies also indicate the presence of clinical manifestations that meet the criteria of acute viral conjunctivitis. Ocular transmission can occur because when a pathogen in the eye, it is partially absorbed by the cornea and the conjunctiva and is largely flowed into the nasal cavity through the nasolacrimal tract and then transported to the lower part of the respiratory tract, including the nasopharynx and trachea, or swallowed into the gastrointestinal tract. This allows the pathogens about the eye to be carried up to the respiratory tract and the gastrointestinal tract.
Kemenkes. Pedoman pencegahan dan pengendalian coronavirus disease (covid-19) revisi ke-4. Kementerian Kesehatan RI. Direktorat Jenderal Pencegahan dan Pengendalian Penyakit (P2P). 2020.
Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. Journal of Virology. 2020.
Wu C, Chen X, Cai Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. Jama Internal Medicine. 2020.
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. 2020.
Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol. 2020.
Lu C-W, Liu X- F, Jia Z- F. 2019- nCoV transmission through the ocular surface must not be ignored. Lancet 2020.
Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol.2020.
Zhang X, Chen X, Chen L, Deng C, Zou X, Liu W, et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocular Surf. 2020.
Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020.
Belser JA, Rota PA, Tumpey TM. Ocular tropism of respiratory viruses. Microbiol Mol Biol Rev. 2013; 77:144–56.
Tong TR, Lam BH, Ng TK, Lai ST, Tong MK, Chau TN.Conjunctivaupper respiratory tract irrigation for early diagnosisof severe acute respiratory syndrome. J Clin Microbiol.2003; 41:5352–2.
Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissuedistribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol.2004; 203:631–7.
Liu L, Sun Y, Pan X, Shen W, Liu ZY, Liu YP. Expression of SARS coronavirus S protein functional receptor- angiotensin-converting enzyme2 in human cornea and conjunctiva. Chin Ophthal Res. 2004; 22:561–4.
Sun Y, Liu L, Pan X, Jing M. Mechanism of the action between the SARS- CoVS240 protein and the ACE2 receptor in eyes. Int J Ophthalmol. 2006; 6:783–6.
Milewska A, Nowak P, Owczarek K, Szczepanski A, Zarebski M, Hoang A, et al. Entry of human coronavirus NL63 into the cell. J Virol.2018; 92.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet.2020; 395:565–74.
Milewska A, Nowak P, Owczarek K, Szczepanski A, Zarebski M, HoangA, et al. Entry of human coronavirus NL63 into the Cell. J Virol.2018.
Orr-Burks N, Gulley SL, Toro H, van Ginkel FW. Immunoglobulin A as anearly humoral responder after mucosal avian coronavirus vaccination. AvianDis.2014; 58:279–86.
How to Cite
Copyright (c) 2020 MEDULA
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.